July 19, 2007
Night Music, JFS, Tobin et al.
The Center for Jewish Culture and Creativity recently held a memorial concert to honor the legacy of founding visionary John Rauch.
In support of its mission to sustain Jewish identity through creativity, the center hosted an afternoon of international Jewish music and performance.
Some of the world's leading contemporary Jewish artists donated their time and talent to celebrate a man whose life reflected a love for Jewish culture and artistry.
The Yuval Ron Ensemble produced the concert, which featured klezmer musician Yale Strom, singer Sam Glaser and the words of playwright Yehuda Hyman. Sha-Rone Kushnir added his piano playing and composer Russell Steinberg plucked the guitar strings at the moving musical ceremony.
Rauch's wife, Ruth, the center's co-founder and program director, graciously posed in front of the camera with a slew of Jewish actors, singers, musicians, playwrights and performance artists.
Rabbi Lynn Brody, the center's president, dazzled in her red dress and thanked the supporters for helping continue to realize the creative vision Rauch left behind.
"People who knew John were so moved by this powerful way to remember him," said Ravit Markus, director of strategic planning. "People who didn't know him wish they did, because of the positive impact he had on Jewish culture and creativity around the world."
Tobin on Top
Jewish Family Service (JFS) attracted more than 500 people to support their shared community interest in providing vital services to people of all ages, ethnicities and religions. The event theme, "Many Faces, One Family," spoke to the spirit of the evening at the Beverly Wilshire on May 30, when $510,000 was raised to support the JFS mission.
Mark Tobin, who has led a distinguished career in financial services, was honored for the tremendous growth of the JFS endowment under his leadership. The JFS endowment campaign expanded from $2 million to $12 million with Tobin at its helm.
Sportscaster, Emmy-winner and accomplished singer and humorist Roy Firestone entertained the large crowd with musical impersonations of John Lennon, Frank Sinatra and Sammy Davis Jr.
Head of the Class
Maimonides Academy seventh-grader Noah Cherner was recognized for academic excellence by Johns Hopkins University's Center for Talented Youth (CTY) at a special ceremony June 3 at Occidental College. CTY sponsors a yearly talent search program where nearly 83,000 students are tested for exceptional verbal and mathematics skills. Second- through sixth-graders take the SCAT, a version of the SAT calibrated for younger students. Seventh- and eighth-graders take the SAT college admissions test, and Cherner scored 610 on the math portion of the exam.
Based on his outstanding score, Cherner was admitted to the prestigious CTY, a nonprofit organization, and presented with a state award for being among the highest scoring participants in California. The CTY features elite academic summer programs and distance education courses for accelerated students like Cherner. Its goal is to recognize students with high academic potential and ability. Among students who received awards were: Ethan Algazi, Maggie Bass, Jacob Blum, Andrew Fischmann, Samantha Gasmer, Allen Gozini, Bailey Share-Aizic, Eli Levinson, Ayal Marom and Adam Weinstein.
New Cancer Center
Los Angeles medical care reached new standards of excellence with the late May opening of Premiere Oncology's 28,000- square-foot cancer research and treatment center in Santa Monica. Premiere Oncology provides comprehensive hematology and oncology care, along with its sister location in Scottsdale, AZ.
The new facility, built under the supervision of president and founder Dr. Lee Rosen, will offer top-notch medical care, faster.
"In order to bring a broader range of treatments to patients faster, the most innovative and cutting-edge therapies are now offered outside the large, traditional medical institutions and universities," said Rosen at the facility's opening.
Premiere Oncology is considered the largest cancer research facility in Los Angeles and among the largest Phase 1 clinical trial centers in the country.